Cargando…
Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature
Tumor-induced osteomalacia (TIO), or oncogenic osteomalacia (OOM), is a rare acquired Paraneoplastic disease characterized by renal phosphate wasting and hypophosphatemia. Recent evidence shows that tumor-overexpressed fibroblast growth factor 23 (FGF23) is responsible for the hypophosphatemia and o...
Autores principales: | Hu, Fang-Ke, Yuan, Fang, Jiang, Cheng-Ying, Lv, Da-Wei, Mao, Bei-Bei, Zhang, Qiang, Yuan, Zeng-Qiang, Wang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sun Yat-sen University Cancer Center
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013303/ https://www.ncbi.nlm.nih.gov/pubmed/22035861 http://dx.doi.org/10.5732/cjc.011.10013 |
Ejemplares similares
-
Fibroblast Growth Factor 23-Producing Phosphaturic Mesenchymal Tumor with Extraordinary Morphology Causing Oncogenic Osteomalacia
por: Then, Cornelia, et al.
Publicado: (2020) -
Intracranial phosphaturic mesenchymal tumor, mixed connective tissue variant presenting without oncogenic osteomalacia
por: Bower, Regina S., et al.
Publicado: (2012) -
Tumor-induced osteomalacia caused by a phosphaturic mesenchymal tumor of the femur
por: Liu, Shu-Zhong, et al.
Publicado: (2019) -
A case report of phosphaturic mesenchymal tumor-induced osteomalacia
por: Wu, Weiqian, et al.
Publicado: (2017) -
Successful treatment of tumor-induced osteomalacia causing by phosphaturic mesenchymal tumor of the foot
por: Liu, Shuzhong, et al.
Publicado: (2019)